Savara Inc (SVRA)
2.90 -0.11 (-3.65%) 15:01 ET [NASDAQ]
2.90 x 100 2.91 x 465
Realtime by (Cboe BZX)
2.90 x 100 2.91 x 465
Realtime 2.96 -0.05 (-1.66%) 08:05 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select FieldsSymbol | SVRA | KALV | USNA | ||
Company | Savara Inc | Kalvista Pharmaceuticals Inc | Usana Health Sciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | ||
Open | 2.90 | 11.03 | 26.41 | ||
High | 3.00 | 11.19 | 26.42 | ||
Low | 2.82 | 10.55 | 25.26 | ||
Last | 2.89 | 11.19 | 25.43 | ||
Change | -0.12 | +0.10 | -1.72 | ||
% Change | -3.99% | +0.90% | -6.34% | ||
Volume | 473,917 | 540,960 | 88,372 | ||
20-Day Average Volume | 1,340,740 | 589,830 | 220,573 | ||
Previous Close | 3.01 | 11.09 | 27.15 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.78 | 12.02 | 28.62 | ||
20-Day Raw Stochastic | 81.51% | 18.67% | 1.24% | ||
20-Day Relative Strength | 53.94% | 48.32% | 34.12% | ||
Weighted Alpha | -33.91 | +0.29 | -49.84 | ||
Today's Opinion | 40% Sell | 32% Buy | 100% Sell | ||
Previous Opinion | 24% Sell | 40% Buy | 100% Sell | ||
Last Month's Opinion | 100% Sell | 24% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +4.68% since 03/27/25 | -10.29% since 03/27/25 | -9.92% since 03/27/25 | ||
Low | 2.68 on 03/31/25 | 10.65 on 04/03/25 | 25.26 on 04/03/25 | ||
High | 3.02 on 04/02/25 | 12.50 on 03/28/25 | 28.11 on 03/28/25 | ||
1-Month | |||||
%Chg | +25.43% since 03/03/25 | +1.84% since 03/03/25 | -15.39% since 03/03/25 | ||
Low | 2.26 on 03/04/25 | 10.53 on 03/04/25 | 25.26 on 04/03/25 | ||
High | 3.02 on 04/02/25 | 12.90 on 03/12/25 | 33.88 on 03/10/25 | ||
3-Month | |||||
%Chg | -7.32% since 01/03/25 | +22.59% since 01/03/25 | -29.87% since 01/03/25 | ||
Low | 2.26 on 03/04/25 | 7.30 on 01/13/25 | 25.26 on 04/03/25 | ||
High | 3.15 on 01/06/25 | 12.90 on 03/12/25 | 36.54 on 01/06/25 | ||
6-Month | |||||
%Chg | -23.62% since 10/03/24 | -4.07% since 10/03/24 | -28.40% since 10/03/24 | ||
Low | 2.26 on 03/04/25 | 7.30 on 01/13/25 | 25.26 on 04/03/25 | ||
High | 4.30 on 11/12/24 | 12.90 on 03/12/25 | 41.83 on 11/11/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 519,625 | 551,350 | 513,271 | ||
Shares Outstanding, K | 172,633 | 49,716 | 18,905 | ||
Annual Sales | 0 | 0 | 854,500,000 | ||
Annual Net Income | -95,880,000 | -126,640,000 | 42,030,000 | ||
Last Quarter Sales | 0 | 0 | 213,610,000 | ||
Last Quarter Net Income | -29,040,000 | -48,510,000 | 4,450,000 | ||
60-Month Beta | 0.52 | 0.39 | 1.00 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.13 on 03/27/25 | -0.92 on 03/12/25 | 0.64 on 02/25/25 | ||
Latest Earnings Date | 05/08/25 | 03/10/25 | 04/29/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 10.48 |